Global Neuromyelitis Optica Therapy Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren't yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord.
Neuromyelitis optica drug is drug used in the treatment of neuromyelitis optica, in this report we focused on Glucocorticoids such as Methylprednisolone and Immunoglobulin such as IVIg.
LPI (LP Information)' newest research report, the “Neuromyelitis Optica Therapy Industry Forecast” looks at past sales and reviews total world Neuromyelitis Optica Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Neuromyelitis Optica Therapy sales for 2023 through 2029. With Neuromyelitis Optica Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuromyelitis Optica Therapy industry.
This Insight Report provides a comprehensive analysis of the global Neuromyelitis Optica Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neuromyelitis Optica Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neuromyelitis Optica Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuromyelitis Optica Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuromyelitis Optica Therapy.
The global Neuromyelitis Optica Therapy market size is projected to grow from US$ 46 million in 2022 to US$ 59 million in 2029; it is expected to grow at a CAGR of 3.5% from 2023 to 2029.
Europe is the largest Neuromyelitis Optica Drug market with about 40% market share. North America is follower, accounting for about 35% market share.
The key players are Pfizer, Fresenius, Teva, Sandoz, Intas, Gyjtrs, NANG KUANG, Tianjin Kingyork, Baxter, CSL, Grifols, Octapharma, CBOP etc. Top 3 companies occupied about 35% market share.
This report presents a comprehensive overview, market shares, and growth opportunities of Neuromyelitis Optica Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren't yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord.
Neuromyelitis optica drug is drug used in the treatment of neuromyelitis optica, in this report we focused on Glucocorticoids such as Methylprednisolone and Immunoglobulin such as IVIg.
LPI (LP Information)' newest research report, the “Neuromyelitis Optica Therapy Industry Forecast” looks at past sales and reviews total world Neuromyelitis Optica Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Neuromyelitis Optica Therapy sales for 2023 through 2029. With Neuromyelitis Optica Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuromyelitis Optica Therapy industry.
This Insight Report provides a comprehensive analysis of the global Neuromyelitis Optica Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neuromyelitis Optica Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neuromyelitis Optica Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuromyelitis Optica Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuromyelitis Optica Therapy.
The global Neuromyelitis Optica Therapy market size is projected to grow from US$ 46 million in 2022 to US$ 59 million in 2029; it is expected to grow at a CAGR of 3.5% from 2023 to 2029.
Europe is the largest Neuromyelitis Optica Drug market with about 40% market share. North America is follower, accounting for about 35% market share.
The key players are Pfizer, Fresenius, Teva, Sandoz, Intas, Gyjtrs, NANG KUANG, Tianjin Kingyork, Baxter, CSL, Grifols, Octapharma, CBOP etc. Top 3 companies occupied about 35% market share.
This report presents a comprehensive overview, market shares, and growth opportunities of Neuromyelitis Optica Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Glucocorticoids
- Immunotherapies
- Other
- Acute Attack
- Remission Prophylactic Treatment
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Fresenius
- Teva
- Sandoz
- Intas
- Gyjtrs
- NANG KUANG
- Tianjin Kingyork
- Baxter
- CSL
- Grifols
- Octapharma
- CBOP
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuromyelitis Optica Therapy Market Size 2018-2029
2.1.2 Neuromyelitis Optica Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Neuromyelitis Optica Therapy Segment by Type
2.2.1 Glucocorticoids
2.2.2 Immunotherapies
2.2.3 Other
2.3 Neuromyelitis Optica Therapy Market Size by Type
2.3.1 Neuromyelitis Optica Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Neuromyelitis Optica Therapy Market Size Market Share by Type (2018-2023)
2.4 Neuromyelitis Optica Therapy Segment by Application
2.4.1 Acute Attack
2.4.2 Remission Prophylactic Treatment
2.5 Neuromyelitis Optica Therapy Market Size by Application
2.5.1 Neuromyelitis Optica Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Neuromyelitis Optica Therapy Market Size Market Share by Application (2018-2023)
3 NEUROMYELITIS OPTICA THERAPY MARKET SIZE BY PLAYER
3.1 Neuromyelitis Optica Therapy Market Size Market Share by Players
3.1.1 Global Neuromyelitis Optica Therapy Revenue by Players (2018-2023)
3.1.2 Global Neuromyelitis Optica Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Neuromyelitis Optica Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROMYELITIS OPTICA THERAPY BY REGIONS
4.1 Neuromyelitis Optica Therapy Market Size by Regions (2018-2023)
4.2 Americas Neuromyelitis Optica Therapy Market Size Growth (2018-2023)
4.3 APAC Neuromyelitis Optica Therapy Market Size Growth (2018-2023)
4.4 Europe Neuromyelitis Optica Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Neuromyelitis Optica Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Neuromyelitis Optica Therapy Market Size by Country (2018-2023)
5.2 Americas Neuromyelitis Optica Therapy Market Size by Type (2018-2023)
5.3 Americas Neuromyelitis Optica Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuromyelitis Optica Therapy Market Size by Region (2018-2023)
6.2 APAC Neuromyelitis Optica Therapy Market Size by Type (2018-2023)
6.3 APAC Neuromyelitis Optica Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neuromyelitis Optica Therapy by Country (2018-2023)
7.2 Europe Neuromyelitis Optica Therapy Market Size by Type (2018-2023)
7.3 Europe Neuromyelitis Optica Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuromyelitis Optica Therapy by Region (2018-2023)
8.2 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROMYELITIS OPTICA THERAPY MARKET FORECAST
10.1 Global Neuromyelitis Optica Therapy Forecast by Regions (2024-2029)
10.1.1 Global Neuromyelitis Optica Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Neuromyelitis Optica Therapy Forecast
10.1.3 APAC Neuromyelitis Optica Therapy Forecast
10.1.4 Europe Neuromyelitis Optica Therapy Forecast
10.1.5 Middle East & Africa Neuromyelitis Optica Therapy Forecast
10.2 Americas Neuromyelitis Optica Therapy Forecast by Country (2024-2029)
10.2.1 United States Neuromyelitis Optica Therapy Market Forecast
10.2.2 Canada Neuromyelitis Optica Therapy Market Forecast
10.2.3 Mexico Neuromyelitis Optica Therapy Market Forecast
10.2.4 Brazil Neuromyelitis Optica Therapy Market Forecast
10.3 APAC Neuromyelitis Optica Therapy Forecast by Region (2024-2029)
10.3.1 China Neuromyelitis Optica Therapy Market Forecast
10.3.2 Japan Neuromyelitis Optica Therapy Market Forecast
10.3.3 Korea Neuromyelitis Optica Therapy Market Forecast
10.3.4 Southeast Asia Neuromyelitis Optica Therapy Market Forecast
10.3.5 India Neuromyelitis Optica Therapy Market Forecast
10.3.6 Australia Neuromyelitis Optica Therapy Market Forecast
10.4 Europe Neuromyelitis Optica Therapy Forecast by Country (2024-2029)
10.4.1 Germany Neuromyelitis Optica Therapy Market Forecast
10.4.2 France Neuromyelitis Optica Therapy Market Forecast
10.4.3 UK Neuromyelitis Optica Therapy Market Forecast
10.4.4 Italy Neuromyelitis Optica Therapy Market Forecast
10.4.5 Russia Neuromyelitis Optica Therapy Market Forecast
10.5 Middle East & Africa Neuromyelitis Optica Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Neuromyelitis Optica Therapy Market Forecast
10.5.2 South Africa Neuromyelitis Optica Therapy Market Forecast
10.5.3 Israel Neuromyelitis Optica Therapy Market Forecast
10.5.4 Turkey Neuromyelitis Optica Therapy Market Forecast
10.5.5 GCC Countries Neuromyelitis Optica Therapy Market Forecast
10.6 Global Neuromyelitis Optica Therapy Forecast by Type (2024-2029)
10.7 Global Neuromyelitis Optica Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Neuromyelitis Optica Therapy Product Offered
11.1.3 Pfizer Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Fresenius
11.2.1 Fresenius Company Information
11.2.2 Fresenius Neuromyelitis Optica Therapy Product Offered
11.2.3 Fresenius Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Fresenius Main Business Overview
11.2.5 Fresenius Latest Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Neuromyelitis Optica Therapy Product Offered
11.3.3 Teva Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Teva Main Business Overview
11.3.5 Teva Latest Developments
11.4 Sandoz
11.4.1 Sandoz Company Information
11.4.2 Sandoz Neuromyelitis Optica Therapy Product Offered
11.4.3 Sandoz Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Sandoz Main Business Overview
11.4.5 Sandoz Latest Developments
11.5 Intas
11.5.1 Intas Company Information
11.5.2 Intas Neuromyelitis Optica Therapy Product Offered
11.5.3 Intas Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Intas Main Business Overview
11.5.5 Intas Latest Developments
11.6 Gyjtrs
11.6.1 Gyjtrs Company Information
11.6.2 Gyjtrs Neuromyelitis Optica Therapy Product Offered
11.6.3 Gyjtrs Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Gyjtrs Main Business Overview
11.6.5 Gyjtrs Latest Developments
11.7 NANG KUANG
11.7.1 NANG KUANG Company Information
11.7.2 NANG KUANG Neuromyelitis Optica Therapy Product Offered
11.7.3 NANG KUANG Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 NANG KUANG Main Business Overview
11.7.5 NANG KUANG Latest Developments
11.8 Tianjin Kingyork
11.8.1 Tianjin Kingyork Company Information
11.8.2 Tianjin Kingyork Neuromyelitis Optica Therapy Product Offered
11.8.3 Tianjin Kingyork Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Tianjin Kingyork Main Business Overview
11.8.5 Tianjin Kingyork Latest Developments
11.9 Baxter
11.9.1 Baxter Company Information
11.9.2 Baxter Neuromyelitis Optica Therapy Product Offered
11.9.3 Baxter Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Baxter Main Business Overview
11.9.5 Baxter Latest Developments
11.10 CSL
11.10.1 CSL Company Information
11.10.2 CSL Neuromyelitis Optica Therapy Product Offered
11.10.3 CSL Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 CSL Main Business Overview
11.10.5 CSL Latest Developments
11.11 Grifols
11.11.1 Grifols Company Information
11.11.2 Grifols Neuromyelitis Optica Therapy Product Offered
11.11.3 Grifols Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Grifols Main Business Overview
11.11.5 Grifols Latest Developments
11.12 Octapharma
11.12.1 Octapharma Company Information
11.12.2 Octapharma Neuromyelitis Optica Therapy Product Offered
11.12.3 Octapharma Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Octapharma Main Business Overview
11.12.5 Octapharma Latest Developments
11.13 CBOP
11.13.1 CBOP Company Information
11.13.2 CBOP Neuromyelitis Optica Therapy Product Offered
11.13.3 CBOP Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 CBOP Main Business Overview
11.13.5 CBOP Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuromyelitis Optica Therapy Market Size 2018-2029
2.1.2 Neuromyelitis Optica Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Neuromyelitis Optica Therapy Segment by Type
2.2.1 Glucocorticoids
2.2.2 Immunotherapies
2.2.3 Other
2.3 Neuromyelitis Optica Therapy Market Size by Type
2.3.1 Neuromyelitis Optica Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Neuromyelitis Optica Therapy Market Size Market Share by Type (2018-2023)
2.4 Neuromyelitis Optica Therapy Segment by Application
2.4.1 Acute Attack
2.4.2 Remission Prophylactic Treatment
2.5 Neuromyelitis Optica Therapy Market Size by Application
2.5.1 Neuromyelitis Optica Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Neuromyelitis Optica Therapy Market Size Market Share by Application (2018-2023)
3 NEUROMYELITIS OPTICA THERAPY MARKET SIZE BY PLAYER
3.1 Neuromyelitis Optica Therapy Market Size Market Share by Players
3.1.1 Global Neuromyelitis Optica Therapy Revenue by Players (2018-2023)
3.1.2 Global Neuromyelitis Optica Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Neuromyelitis Optica Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROMYELITIS OPTICA THERAPY BY REGIONS
4.1 Neuromyelitis Optica Therapy Market Size by Regions (2018-2023)
4.2 Americas Neuromyelitis Optica Therapy Market Size Growth (2018-2023)
4.3 APAC Neuromyelitis Optica Therapy Market Size Growth (2018-2023)
4.4 Europe Neuromyelitis Optica Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Neuromyelitis Optica Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Neuromyelitis Optica Therapy Market Size by Country (2018-2023)
5.2 Americas Neuromyelitis Optica Therapy Market Size by Type (2018-2023)
5.3 Americas Neuromyelitis Optica Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuromyelitis Optica Therapy Market Size by Region (2018-2023)
6.2 APAC Neuromyelitis Optica Therapy Market Size by Type (2018-2023)
6.3 APAC Neuromyelitis Optica Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neuromyelitis Optica Therapy by Country (2018-2023)
7.2 Europe Neuromyelitis Optica Therapy Market Size by Type (2018-2023)
7.3 Europe Neuromyelitis Optica Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuromyelitis Optica Therapy by Region (2018-2023)
8.2 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Neuromyelitis Optica Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROMYELITIS OPTICA THERAPY MARKET FORECAST
10.1 Global Neuromyelitis Optica Therapy Forecast by Regions (2024-2029)
10.1.1 Global Neuromyelitis Optica Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Neuromyelitis Optica Therapy Forecast
10.1.3 APAC Neuromyelitis Optica Therapy Forecast
10.1.4 Europe Neuromyelitis Optica Therapy Forecast
10.1.5 Middle East & Africa Neuromyelitis Optica Therapy Forecast
10.2 Americas Neuromyelitis Optica Therapy Forecast by Country (2024-2029)
10.2.1 United States Neuromyelitis Optica Therapy Market Forecast
10.2.2 Canada Neuromyelitis Optica Therapy Market Forecast
10.2.3 Mexico Neuromyelitis Optica Therapy Market Forecast
10.2.4 Brazil Neuromyelitis Optica Therapy Market Forecast
10.3 APAC Neuromyelitis Optica Therapy Forecast by Region (2024-2029)
10.3.1 China Neuromyelitis Optica Therapy Market Forecast
10.3.2 Japan Neuromyelitis Optica Therapy Market Forecast
10.3.3 Korea Neuromyelitis Optica Therapy Market Forecast
10.3.4 Southeast Asia Neuromyelitis Optica Therapy Market Forecast
10.3.5 India Neuromyelitis Optica Therapy Market Forecast
10.3.6 Australia Neuromyelitis Optica Therapy Market Forecast
10.4 Europe Neuromyelitis Optica Therapy Forecast by Country (2024-2029)
10.4.1 Germany Neuromyelitis Optica Therapy Market Forecast
10.4.2 France Neuromyelitis Optica Therapy Market Forecast
10.4.3 UK Neuromyelitis Optica Therapy Market Forecast
10.4.4 Italy Neuromyelitis Optica Therapy Market Forecast
10.4.5 Russia Neuromyelitis Optica Therapy Market Forecast
10.5 Middle East & Africa Neuromyelitis Optica Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Neuromyelitis Optica Therapy Market Forecast
10.5.2 South Africa Neuromyelitis Optica Therapy Market Forecast
10.5.3 Israel Neuromyelitis Optica Therapy Market Forecast
10.5.4 Turkey Neuromyelitis Optica Therapy Market Forecast
10.5.5 GCC Countries Neuromyelitis Optica Therapy Market Forecast
10.6 Global Neuromyelitis Optica Therapy Forecast by Type (2024-2029)
10.7 Global Neuromyelitis Optica Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Neuromyelitis Optica Therapy Product Offered
11.1.3 Pfizer Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Fresenius
11.2.1 Fresenius Company Information
11.2.2 Fresenius Neuromyelitis Optica Therapy Product Offered
11.2.3 Fresenius Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Fresenius Main Business Overview
11.2.5 Fresenius Latest Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Neuromyelitis Optica Therapy Product Offered
11.3.3 Teva Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Teva Main Business Overview
11.3.5 Teva Latest Developments
11.4 Sandoz
11.4.1 Sandoz Company Information
11.4.2 Sandoz Neuromyelitis Optica Therapy Product Offered
11.4.3 Sandoz Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Sandoz Main Business Overview
11.4.5 Sandoz Latest Developments
11.5 Intas
11.5.1 Intas Company Information
11.5.2 Intas Neuromyelitis Optica Therapy Product Offered
11.5.3 Intas Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Intas Main Business Overview
11.5.5 Intas Latest Developments
11.6 Gyjtrs
11.6.1 Gyjtrs Company Information
11.6.2 Gyjtrs Neuromyelitis Optica Therapy Product Offered
11.6.3 Gyjtrs Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Gyjtrs Main Business Overview
11.6.5 Gyjtrs Latest Developments
11.7 NANG KUANG
11.7.1 NANG KUANG Company Information
11.7.2 NANG KUANG Neuromyelitis Optica Therapy Product Offered
11.7.3 NANG KUANG Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 NANG KUANG Main Business Overview
11.7.5 NANG KUANG Latest Developments
11.8 Tianjin Kingyork
11.8.1 Tianjin Kingyork Company Information
11.8.2 Tianjin Kingyork Neuromyelitis Optica Therapy Product Offered
11.8.3 Tianjin Kingyork Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Tianjin Kingyork Main Business Overview
11.8.5 Tianjin Kingyork Latest Developments
11.9 Baxter
11.9.1 Baxter Company Information
11.9.2 Baxter Neuromyelitis Optica Therapy Product Offered
11.9.3 Baxter Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Baxter Main Business Overview
11.9.5 Baxter Latest Developments
11.10 CSL
11.10.1 CSL Company Information
11.10.2 CSL Neuromyelitis Optica Therapy Product Offered
11.10.3 CSL Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 CSL Main Business Overview
11.10.5 CSL Latest Developments
11.11 Grifols
11.11.1 Grifols Company Information
11.11.2 Grifols Neuromyelitis Optica Therapy Product Offered
11.11.3 Grifols Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Grifols Main Business Overview
11.11.5 Grifols Latest Developments
11.12 Octapharma
11.12.1 Octapharma Company Information
11.12.2 Octapharma Neuromyelitis Optica Therapy Product Offered
11.12.3 Octapharma Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Octapharma Main Business Overview
11.12.5 Octapharma Latest Developments
11.13 CBOP
11.13.1 CBOP Company Information
11.13.2 CBOP Neuromyelitis Optica Therapy Product Offered
11.13.3 CBOP Neuromyelitis Optica Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 CBOP Main Business Overview
11.13.5 CBOP Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neuromyelitis Optica Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Glucocorticoids
Table 3. Major Players of Immunotherapies
Table 4. Major Players of Other
Table 5. Neuromyelitis Optica Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Neuromyelitis Optica Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Neuromyelitis Optica Therapy Market Size Market Share by Type (2018-2023)
Table 8. Neuromyelitis Optica Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Neuromyelitis Optica Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Neuromyelitis Optica Therapy Market Size Market Share by Application (2018-2023)
Table 11. Global Neuromyelitis Optica Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Neuromyelitis Optica Therapy Revenue Market Share by Player (2018-2023)
Table 13. Neuromyelitis Optica Therapy Key Players Head office and Products Offered
Table 14. Neuromyelitis Optica Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Neuromyelitis Optica Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Neuromyelitis Optica Therapy Market Size Market Share by Regions (2018-2023)
Table 19. Global Neuromyelitis Optica Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Neuromyelitis Optica Therapy Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Neuromyelitis Optica Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Neuromyelitis Optica Therapy Market Size Market Share by Country (2018-2023)
Table 23. Americas Neuromyelitis Optica Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Neuromyelitis Optica Therapy Market Size Market Share by Type (2018-2023)
Table 25. Americas Neuromyelitis Optica Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Neuromyelitis Optica Therapy Market Size Market Share by Application (2018-2023)
Table 27. APAC Neuromyelitis Optica Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Neuromyelitis Optica Therapy Market Size Market Share by Region (2018-2023)
Table 29. APAC Neuromyelitis Optica Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Neuromyelitis Optica Therapy Market Size Market Share by Type (2018-2023)
Table 31. APAC Neuromyelitis Optica Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Neuromyelitis Optica Therapy Market Size Market Share by Application (2018-2023)
Table 33. Europe Neuromyelitis Optica Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Neuromyelitis Optica Therapy Market Size Market Share by Country (2018-2023)
Table 35. Europe Neuromyelitis Optica Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Neuromyelitis Optica Therapy Market Size Market Share by Type (2018-2023)
Table 37. Europe Neuromyelitis Optica Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Neuromyelitis Optica Therapy Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Neuromyelitis Optica Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Neuromyelitis Optica Therapy Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Neuromyelitis Optica Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Neuromyelitis Optica Therapy Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Neuromyelitis Optica Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Neuromyelitis Optica Therapy Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Neuromyelitis Optica Therapy
Table 46. Key Market Challenges & Risks of Neuromyelitis Optica Therapy
Table 47. Key Industry Trends of Neuromyelitis Optica Therapy
Table 48. Global Neuromyelitis Optica Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Neuromyelitis Optica Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Neuromyelitis Optica Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Neuromyelitis Optica Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Pfizer Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 53. Pfizer Neuromyelitis Optica Therapy Product Offered
Table 54. Pfizer Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Fresenius Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 58. Fresenius Neuromyelitis Optica Therapy Product Offered
Table 59. Fresenius Main Business
Table 60. Fresenius Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Fresenius Latest Developments
Table 62. Teva Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 63. Teva Neuromyelitis Optica Therapy Product Offered
Table 64. Teva Main Business
Table 65. Teva Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Teva Latest Developments
Table 67. Sandoz Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 68. Sandoz Neuromyelitis Optica Therapy Product Offered
Table 69. Sandoz Main Business
Table 70. Sandoz Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Sandoz Latest Developments
Table 72. Intas Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 73. Intas Neuromyelitis Optica Therapy Product Offered
Table 74. Intas Main Business
Table 75. Intas Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Intas Latest Developments
Table 77. Gyjtrs Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 78. Gyjtrs Neuromyelitis Optica Therapy Product Offered
Table 79. Gyjtrs Main Business
Table 80. Gyjtrs Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Gyjtrs Latest Developments
Table 82. NANG KUANG Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 83. NANG KUANG Neuromyelitis Optica Therapy Product Offered
Table 84. NANG KUANG Main Business
Table 85. NANG KUANG Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. NANG KUANG Latest Developments
Table 87. Tianjin Kingyork Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 88. Tianjin Kingyork Neuromyelitis Optica Therapy Product Offered
Table 89. Tianjin Kingyork Main Business
Table 90. Tianjin Kingyork Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Tianjin Kingyork Latest Developments
Table 92. Baxter Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 93. Baxter Neuromyelitis Optica Therapy Product Offered
Table 94. Baxter Main Business
Table 95. Baxter Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Baxter Latest Developments
Table 97. CSL Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 98. CSL Neuromyelitis Optica Therapy Product Offered
Table 99. CSL Main Business
Table 100. CSL Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. CSL Latest Developments
Table 102. Grifols Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 103. Grifols Neuromyelitis Optica Therapy Product Offered
Table 104. Grifols Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Grifols Main Business
Table 106. Grifols Latest Developments
Table 107. Octapharma Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 108. Octapharma Neuromyelitis Optica Therapy Product Offered
Table 109. Octapharma Main Business
Table 110. Octapharma Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Octapharma Latest Developments
Table 112. CBOP Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 113. CBOP Neuromyelitis Optica Therapy Product Offered
Table 114. CBOP Main Business
Table 115. CBOP Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. CBOP Latest Developments
Table 1. Neuromyelitis Optica Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Glucocorticoids
Table 3. Major Players of Immunotherapies
Table 4. Major Players of Other
Table 5. Neuromyelitis Optica Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Neuromyelitis Optica Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Neuromyelitis Optica Therapy Market Size Market Share by Type (2018-2023)
Table 8. Neuromyelitis Optica Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Neuromyelitis Optica Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Neuromyelitis Optica Therapy Market Size Market Share by Application (2018-2023)
Table 11. Global Neuromyelitis Optica Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Neuromyelitis Optica Therapy Revenue Market Share by Player (2018-2023)
Table 13. Neuromyelitis Optica Therapy Key Players Head office and Products Offered
Table 14. Neuromyelitis Optica Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Neuromyelitis Optica Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Neuromyelitis Optica Therapy Market Size Market Share by Regions (2018-2023)
Table 19. Global Neuromyelitis Optica Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Neuromyelitis Optica Therapy Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Neuromyelitis Optica Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Neuromyelitis Optica Therapy Market Size Market Share by Country (2018-2023)
Table 23. Americas Neuromyelitis Optica Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Neuromyelitis Optica Therapy Market Size Market Share by Type (2018-2023)
Table 25. Americas Neuromyelitis Optica Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Neuromyelitis Optica Therapy Market Size Market Share by Application (2018-2023)
Table 27. APAC Neuromyelitis Optica Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Neuromyelitis Optica Therapy Market Size Market Share by Region (2018-2023)
Table 29. APAC Neuromyelitis Optica Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Neuromyelitis Optica Therapy Market Size Market Share by Type (2018-2023)
Table 31. APAC Neuromyelitis Optica Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Neuromyelitis Optica Therapy Market Size Market Share by Application (2018-2023)
Table 33. Europe Neuromyelitis Optica Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Neuromyelitis Optica Therapy Market Size Market Share by Country (2018-2023)
Table 35. Europe Neuromyelitis Optica Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Neuromyelitis Optica Therapy Market Size Market Share by Type (2018-2023)
Table 37. Europe Neuromyelitis Optica Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Neuromyelitis Optica Therapy Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Neuromyelitis Optica Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Neuromyelitis Optica Therapy Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Neuromyelitis Optica Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Neuromyelitis Optica Therapy Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Neuromyelitis Optica Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Neuromyelitis Optica Therapy Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Neuromyelitis Optica Therapy
Table 46. Key Market Challenges & Risks of Neuromyelitis Optica Therapy
Table 47. Key Industry Trends of Neuromyelitis Optica Therapy
Table 48. Global Neuromyelitis Optica Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Neuromyelitis Optica Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Neuromyelitis Optica Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Neuromyelitis Optica Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Pfizer Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 53. Pfizer Neuromyelitis Optica Therapy Product Offered
Table 54. Pfizer Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Fresenius Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 58. Fresenius Neuromyelitis Optica Therapy Product Offered
Table 59. Fresenius Main Business
Table 60. Fresenius Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Fresenius Latest Developments
Table 62. Teva Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 63. Teva Neuromyelitis Optica Therapy Product Offered
Table 64. Teva Main Business
Table 65. Teva Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Teva Latest Developments
Table 67. Sandoz Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 68. Sandoz Neuromyelitis Optica Therapy Product Offered
Table 69. Sandoz Main Business
Table 70. Sandoz Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Sandoz Latest Developments
Table 72. Intas Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 73. Intas Neuromyelitis Optica Therapy Product Offered
Table 74. Intas Main Business
Table 75. Intas Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Intas Latest Developments
Table 77. Gyjtrs Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 78. Gyjtrs Neuromyelitis Optica Therapy Product Offered
Table 79. Gyjtrs Main Business
Table 80. Gyjtrs Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Gyjtrs Latest Developments
Table 82. NANG KUANG Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 83. NANG KUANG Neuromyelitis Optica Therapy Product Offered
Table 84. NANG KUANG Main Business
Table 85. NANG KUANG Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. NANG KUANG Latest Developments
Table 87. Tianjin Kingyork Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 88. Tianjin Kingyork Neuromyelitis Optica Therapy Product Offered
Table 89. Tianjin Kingyork Main Business
Table 90. Tianjin Kingyork Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Tianjin Kingyork Latest Developments
Table 92. Baxter Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 93. Baxter Neuromyelitis Optica Therapy Product Offered
Table 94. Baxter Main Business
Table 95. Baxter Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Baxter Latest Developments
Table 97. CSL Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 98. CSL Neuromyelitis Optica Therapy Product Offered
Table 99. CSL Main Business
Table 100. CSL Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. CSL Latest Developments
Table 102. Grifols Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 103. Grifols Neuromyelitis Optica Therapy Product Offered
Table 104. Grifols Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Grifols Main Business
Table 106. Grifols Latest Developments
Table 107. Octapharma Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 108. Octapharma Neuromyelitis Optica Therapy Product Offered
Table 109. Octapharma Main Business
Table 110. Octapharma Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Octapharma Latest Developments
Table 112. CBOP Details, Company Type, Neuromyelitis Optica Therapy Area Served and Its Competitors
Table 113. CBOP Neuromyelitis Optica Therapy Product Offered
Table 114. CBOP Main Business
Table 115. CBOP Neuromyelitis Optica Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. CBOP Latest Developments
LIST OF FIGURES
Figure 1. Neuromyelitis Optica Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neuromyelitis Optica Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Neuromyelitis Optica Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Neuromyelitis Optica Therapy Sales Market Share by Country/Region (2022)
Figure 8. Neuromyelitis Optica Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Neuromyelitis Optica Therapy Market Size Market Share by Type in 2022
Figure 10. Neuromyelitis Optica Therapy in Acute Attack
Figure 11. Global Neuromyelitis Optica Therapy Market: Acute Attack (2018-2023) & ($ Millions)
Figure 12. Neuromyelitis Optica Therapy in Remission Prophylactic Treatment
Figure 13. Global Neuromyelitis Optica Therapy Market: Remission Prophylactic Treatment (2018-2023) & ($ Millions)
Figure 14. Global Neuromyelitis Optica Therapy Market Size Market Share by Application in 2022
Figure 15. Global Neuromyelitis Optica Therapy Revenue Market Share by Player in 2022
Figure 16. Global Neuromyelitis Optica Therapy Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Neuromyelitis Optica Therapy Market Size 2018-2023 ($ Millions)
Figure 18. APAC Neuromyelitis Optica Therapy Market Size 2018-2023 ($ Millions)
Figure 19. Europe Neuromyelitis Optica Therapy Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Neuromyelitis Optica Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Americas Neuromyelitis Optica Therapy Value Market Share by Country in 2022
Figure 22. United States Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Neuromyelitis Optica Therapy Market Size Market Share by Region in 2022
Figure 27. APAC Neuromyelitis Optica Therapy Market Size Market Share by Type in 2022
Figure 28. APAC Neuromyelitis Optica Therapy Market Size Market Share by Application in 2022
Figure 29. China Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Neuromyelitis Optica Therapy Market Size Market Share by Country in 2022
Figure 36. Europe Neuromyelitis Optica Therapy Market Size Market Share by Type (2018-2023)
Figure 37. Europe Neuromyelitis Optica Therapy Market Size Market Share by Application (2018-2023)
Figure 38. Germany Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Neuromyelitis Optica Therapy Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Neuromyelitis Optica Therapy Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Neuromyelitis Optica Therapy Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 52. APAC Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 53. Europe Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 55. United States Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Canada Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 59. China Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Japan Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 61. Korea Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 63. India Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Australia Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 65. Germany Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 66. France Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 67. UK Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Italy Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 69. Russia Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Spain Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Israel Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Global Neuromyelitis Optica Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Neuromyelitis Optica Therapy Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Neuromyelitis Optica Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neuromyelitis Optica Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Neuromyelitis Optica Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Neuromyelitis Optica Therapy Sales Market Share by Country/Region (2022)
Figure 8. Neuromyelitis Optica Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Neuromyelitis Optica Therapy Market Size Market Share by Type in 2022
Figure 10. Neuromyelitis Optica Therapy in Acute Attack
Figure 11. Global Neuromyelitis Optica Therapy Market: Acute Attack (2018-2023) & ($ Millions)
Figure 12. Neuromyelitis Optica Therapy in Remission Prophylactic Treatment
Figure 13. Global Neuromyelitis Optica Therapy Market: Remission Prophylactic Treatment (2018-2023) & ($ Millions)
Figure 14. Global Neuromyelitis Optica Therapy Market Size Market Share by Application in 2022
Figure 15. Global Neuromyelitis Optica Therapy Revenue Market Share by Player in 2022
Figure 16. Global Neuromyelitis Optica Therapy Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Neuromyelitis Optica Therapy Market Size 2018-2023 ($ Millions)
Figure 18. APAC Neuromyelitis Optica Therapy Market Size 2018-2023 ($ Millions)
Figure 19. Europe Neuromyelitis Optica Therapy Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Neuromyelitis Optica Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Americas Neuromyelitis Optica Therapy Value Market Share by Country in 2022
Figure 22. United States Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Neuromyelitis Optica Therapy Market Size Market Share by Region in 2022
Figure 27. APAC Neuromyelitis Optica Therapy Market Size Market Share by Type in 2022
Figure 28. APAC Neuromyelitis Optica Therapy Market Size Market Share by Application in 2022
Figure 29. China Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Neuromyelitis Optica Therapy Market Size Market Share by Country in 2022
Figure 36. Europe Neuromyelitis Optica Therapy Market Size Market Share by Type (2018-2023)
Figure 37. Europe Neuromyelitis Optica Therapy Market Size Market Share by Application (2018-2023)
Figure 38. Germany Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Neuromyelitis Optica Therapy Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Neuromyelitis Optica Therapy Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Neuromyelitis Optica Therapy Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Neuromyelitis Optica Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 52. APAC Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 53. Europe Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 55. United States Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Canada Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 59. China Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Japan Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 61. Korea Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 63. India Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Australia Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 65. Germany Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 66. France Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 67. UK Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Italy Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 69. Russia Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Spain Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Israel Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Neuromyelitis Optica Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Global Neuromyelitis Optica Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Neuromyelitis Optica Therapy Market Size Market Share Forecast by Application (2024-2029)
